EUROEYES (01846) posts HK$13.56 million interim net loss after swinging from prior-year profit
Stock News
Aug 31
EUROEYES (01846) has released its interim results for the six months ended 30 June 2026, reporting a revenue of HK$454 million, up 20.5% year-on-year. The company recorded a loss attributable to shareholders of HK$13.561 million, marking a sharp reversal from the profit posted in the same period last year, with a loss per share of 4.254 HK cents.
According to the company's announcement, the significant expansion in presbyopia correction treatments, along with the consolidation of its Swiss business, were the key drivers behind the revenue growth during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.